AU2001244421A1 - Method for predicting predisposition to a disease associated with mutations in a rpgr gene - Google Patents

Method for predicting predisposition to a disease associated with mutations in a rpgr gene

Info

Publication number
AU2001244421A1
AU2001244421A1 AU2001244421A AU4442101A AU2001244421A1 AU 2001244421 A1 AU2001244421 A1 AU 2001244421A1 AU 2001244421 A AU2001244421 A AU 2001244421A AU 4442101 A AU4442101 A AU 4442101A AU 2001244421 A1 AU2001244421 A1 AU 2001244421A1
Authority
AU
Australia
Prior art keywords
mutations
disease associated
rpgr gene
predicting predisposition
predisposition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001244421A
Inventor
Alan Wright
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Research Council filed Critical Medical Research Council
Publication of AU2001244421A1 publication Critical patent/AU2001244421A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001244421A 2000-04-10 2001-04-10 Method for predicting predisposition to a disease associated with mutations in a rpgr gene Abandoned AU2001244421A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0008801.3 2000-04-10
GBGB0008801.3A GB0008801D0 (en) 2000-04-10 2000-04-10 Sequences
PCT/GB2001/001622 WO2001077380A2 (en) 2000-04-10 2001-04-10 Method for predicting predisposition to a disease associated with mutations in a rpgr gene

Publications (1)

Publication Number Publication Date
AU2001244421A1 true AU2001244421A1 (en) 2001-10-23

Family

ID=9889600

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001244421A Abandoned AU2001244421A1 (en) 2000-04-10 2001-04-10 Method for predicting predisposition to a disease associated with mutations in a rpgr gene

Country Status (3)

Country Link
AU (1) AU2001244421A1 (en)
GB (1) GB0008801D0 (en)
WO (1) WO2001077380A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3155128B1 (en) * 2014-06-10 2019-05-15 Erasmus University Medical Center Rotterdam Methods for characterizing alternatively or aberrantly spliced mrna isoforms
GB201412011D0 (en) * 2014-07-04 2014-08-20 Ucl Business Plc Treatments
US10314924B2 (en) 2014-07-24 2019-06-11 Massachusetts Eye & Ear Infirmary RPGR gene therapy for retinitis pigmentosa
GB201516066D0 (en) 2015-09-10 2015-10-28 Young & Co Llp D Treatment of retinitis pigmentosa
CN106987637B (en) * 2017-04-25 2020-06-02 郑州大学第一附属医院 Amplification primer and kit for detecting familial retinitis pigmentosa disease-causing gene mutation and application

Also Published As

Publication number Publication date
GB0008801D0 (en) 2000-05-31
WO2001077380A2 (en) 2001-10-18
WO2001077380A3 (en) 2002-09-06

Similar Documents

Publication Publication Date Title
AU2002227866A1 (en) Method for quantifying cytosine methylations in genomic dna that is amplified in a complex manner
AU2003277121A1 (en) Managing changes in a relationship management system
AU2002244157A1 (en) Extracting cell shape information contained in cell images
AU2001241848A1 (en) Methods for manipulating data in multiple dimensions
AU2003279678A1 (en) Arrangement and method for determining charging in a telecommunications system
AU2003248367A1 (en) A method and distributed rating system for determining rating data in a charging system
AU4328000A (en) Techniques for performing a data query in a computer system
AU3868100A (en) System and method for determining cluster membership in a heterogeneous distributed system
AU5882900A (en) Computer in a wall
AU2001244421A1 (en) Method for predicting predisposition to a disease associated with mutations in a rpgr gene
AU7025700A (en) Polymorphisms in a klotho gene
AU2001262063A1 (en) Method for increasing gene copy number in a host cell and resulting host cell
AUPR311601A0 (en) Matrix gene expression in chondrogenesis
WO2003061564A8 (en) Gene expression profiles in liver disease
IL154099A0 (en) A method and kit for enhancing oligonucleotide-mediated gene alteration
AU2001270635A1 (en) Method for detecting mutations in nucleotide sequences
AU2001273183A1 (en) Method for predicting battery capacity
GB2398967B (en) A handover method in a GPRS System
TW478606U (en) Reverse-U shaped axle structure for notebook computer
AU2153401A (en) Gene expression in biological conditions
AU2003268619A1 (en) A method for constructing a blind-ditch type double-level interchange road
AU2002227292A1 (en) Process for detecting low abundance rna in intact cells
AU2001257427A1 (en) Rna metabolism proteins
AU2002364497A1 (en) Method for reducing the bus load in a synchronous data bus system
AU2001225342A1 (en) Susceptibility gene for autoimmune disease